Open in QuartrAvailable for iOS and Android

Beam Therapeutics Inc
Beam Therapeutics Inc. operates as a clinical-stage biotechnology company, which develops base editing technology to treat serious diseases by making precise changes to DNA and RNA. Its portfolio includes target genes that cover oncology, hematology, ophthalmology, liver disease and neurology conditions. The company was founded by David Nelles, Matthew Porteus and Feng Zhang on April 10, 2018 and is headquartered in Cambridge, MA.
Latest events on Quartr
Previous Events for Beam Therapeutics Inc
Ticker
BEAM
Country
United States of America